Tirofiban, a GPIIb/IIIa antagonist, reduces inflammatory response to percutaneous coronary intervention for single vessel disease in diabetic patients with chronic stable anigna
Suez Canal University Medical Journal. 2005; 8 (2): 197-204
in English
| IMEMR
| ID: emr-75199
Subject(s)
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Tyrosine
/
C-Reactive Protein
/
Platelet Aggregation Inhibitors
/
Chronic Disease
/
Platelet Glycoprotein GPIIb-IIIa Complex
/
Diabetes Mellitus
/
Angina Pectoris
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Suez Canal Univ. Med. J.
Year:
2005
Similar
MEDLINE
...
LILACS
LIS